|
Volumn 17, Issue 5, 2001, Pages 401-414
|
Cyclooxygenase inhibitors are potent sensitizers of prostate tumours to hyperthermia and radiation
a a a a a a a a |
Author keywords
Cyclooxygenase; Hyperthermia; Non steroidal anti inflammatory drugs; Prostate cancer; Radiation; Thermotolerance
|
Indexed keywords
IBUPROFEN;
LEUKOTRIENE B4;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN;
PROSTAGLANDIN E2;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SULINDAC;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER INHIBITION;
CANCER RADIOTHERAPY;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG RESPONSE;
DRUG USE;
HEAT TOLERANCE;
HYPERTHERMIC THERAPY;
MALE;
MOUSE;
NONHUMAN;
PROSTAGLANDIN BLOOD LEVEL;
PROSTAGLANDIN RELEASE;
PROSTAGLANDIN SYNTHESIS INHIBITION;
PROSTATE TUMOR;
RADIOSENSITIZATION;
SENSITIZATION;
SERUM;
TUMOR GROWTH;
ANIMALS;
COMBINED MODALITY THERAPY;
CYCLOOXYGENASE INHIBITORS;
DINOPROSTONE;
HUMANS;
HYPERTHERMIA, INDUCED;
IBUPROFEN;
LEUKOTRIENE B4;
MALE;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
PROSTATIC NEOPLASMS;
RADIATION-SENSITIZING AGENTS;
SULINDAC;
|
EID: 0034815387
PISSN: 02656736
EISSN: None
Source Type: Journal
DOI: 10.1080/02656730110058600 Document Type: Article |
Times cited : (11)
|
References (32)
|